QLQX has been found to improve cardiac hypertrophy by upregulating PPARγ and PGC-1α, reduce cardiomyocyte apoptosis caused by high-glucose environments, and prevent and treat heart failure through various mechanisms, including upregulation of PPARγ and downregulation of miRNA-22. This evidence concerns the gene PPARG and heart failure.